Redmond Asset Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$275K Sell
2022
Q2
$182K Sell
2022
Q1
$399K Buy
2021
Q4
$420K Sell
2021
Q3
$548K Hold
2021
Q2
$795K Sell
2021
Q1
$831K Buy
2020
Q4
$1.08M Buy
2020
Q3
$689K Buy
2020
Q2
$681K Sell
2020
Q1
$546K Buy
2019
Q4
$1.08M Buy
2019
Q3
$844K Buy
2019
Q2
$847K Buy
2019
Q1
$1.1M Buy